Aspen Pharmacare Holdings (APN.JO) Hisse Fiyat
Aspen Pharmacare Holdings Fiyat
Aspen Pharmacare Holdings, son 19 yılda gelirini yıllık %12,0 artırarak 34,87 Md ZAR seviyesine taşıdı. Hisse başına kâr, son 19 yılda yıllık %6,1 büyüdü. Aspen Pharmacare Holdings için net marj, %7,6 ile birkaç yıl önceki %16,8 seviyesine göre geriledi. Bugünkü fiyata göre temettü verimi kabaca %1,28 seviyesine denk geliyor. Temettü dağıtım oranı, kârın yaklaşık %28 düzeyindedir. Temettü, son 19 yılda yıllık %6,1 artış gösterdi. Aspen Pharmacare Holdings için 12 aylık konsensüs fiyat hedefi 117,30 ZAR; bu, hissenin bugünkü fiyatının yaklaşık %28,7 altında bir seviyeye denk geliyor. 10 analistten 0 tanesi hisse için alım öneriyor — genel konsensüs: Tut.
Aspen Pharmacare Holdings hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Aspen Pharmacare Holdings iş modeli ve hisse analizi
Aspen Pharmacare Holdings hakkında sık sorulan sorular
The business model of Aspen Pharmacare Holdings Ltd is focused on the manufacturing and marketing of pharmaceutical and healthcare products. Aspen Pharmacare is a leading global supplier of branded and generic pharmaceuticals, as well as infant nutritionals and consumer healthcare products. With a diverse portfolio of products, the company operates across multiple therapeutic areas including anaesthetics, thrombosis, oncology, and respiratory. Aspen Pharmacare also engages in extensive research and development activities to drive innovation within the pharmaceutical industry. Its commitment to quality and affordability ensures the availability of essential medicines to a wide range of markets worldwide.
Aspen Pharmacare Holdings Ltd is primarily active in the pharmaceutical industry.
The main competitors of Aspen Pharmacare Holdings Ltd in the market are Teva Pharmaceutical Industries Ltd, Mylan N.V., and Sun Pharmaceutical Industries Ltd.
Aspen Pharmacare Holdings Ltd, commonly known as Aspen, is a leading global pharmaceutical company with a rich history and strong background. Founded in 1850 and headquartered in Durban, South Africa, Aspen has grown into a reputable player in the healthcare industry. The company specializes in the manufacturing and distribution of both branded and generic pharmaceutical products across various therapeutic areas. With a diversified portfolio, Aspen operates in more than 150 countries, serving patients and healthcare professionals worldwide. Over the years, Aspen has made strategic acquisitions and formed partnerships to expand its product offerings and global reach. With a commitment to improving patient lives, Aspen continues to drive innovation and deliver quality healthcare solutions globally.
Aspen Pharmacare Holdings Ltd, a leading pharmaceutical company, has achieved several significant milestones. Over the years, the company has expanded its global presence and diversified its product portfolio. It has successfully acquired and integrated multiple companies, enhancing its market reach and capabilities. Aspen Pharmacare has also developed and launched innovative medicines, contributing to advancements in healthcare. The company has received numerous industry awards and recognition, further highlighting its commitment to excellence. With a strong focus on research and development, Aspen Pharmacare continues to make substantial contributions to the healthcare industry, delivering high-quality solutions to patients worldwide.
Aspen Pharmacare Holdings Ltd is primarily present in various countries and regions worldwide. Some of the key markets where the company operates include South Africa, where it is headquartered, as well as other African countries such as Kenya, Nigeria, and Ethiopia. Additionally, Aspen Pharmacare has a significant presence in Latin American countries including Brazil and Mexico. The company has also expanded its operations into Europe, with a focus on countries like Germany, Spain, Italy, and the United Kingdom. Furthermore, Aspen Pharmacare has a presence in the Asia-Pacific region, including Australia, China, and India.
Aspen Pharmacare Holdings Ltd represents a strong set of values and a clear corporate philosophy. The company aims to provide affordable medicines of high quality to people around the world, thus improving their health and well-being. Aspen Pharmacare values integrity, innovation, and accountability in all aspects of its operations. It focuses on sustainable growth and strategic partnerships to expand its global presence and reach. Aspen Pharmacare is committed to providing access to essential healthcare solutions and ensuring patient safety. With its dedicated workforce and commitment to excellence, Aspen Pharmacare continues to make a positive impact in the pharmaceutical industry.
Analistler şu anda Aspen Pharmacare Holdings hissesi için ortalama 120,02 ZAR hedef fiyat belirliyor (medyan: 117,30 ZAR); bu, son fiyata göre -27,0 % anlamına gelir. Konsensüs 10 analist notuna dayanır.
10 analist şu anda Aspen Pharmacare Holdings hissesini değerlendiriyor: 0 al, 6 tut, 4 sat öneriyor.
Güncel döviz kuruyla Aspen Pharmacare Holdings hissesi 8,84 EUR (164,45 ZAR) seviyesindedir.
Aspen Pharmacare Holdings hissesi (APN.JO) 5 borsada işlem görür, bunlar arasında: JSE (Johannesburg) (APN.JO), Frankfurt (LDZA.F), München (LDZA.MU), Düsseldorf (LDZA.DU).
Aspen Pharmacare Holdings Ltd is an international pharmaceutical company based in South Africa. The company specializes in the production and distribution of pharmaceuticals, biopharmaceuticals, and active ingredients. It is one of the largest manufacturers of generics in Africa. The company's business model is characterized by intensive R&D work and a strong presence in Africa. It produces a wide range of pharmaceutical products for various fields such as psychiatry, oncology, gastroenterology, and pain therapy. Aspen is also a significant provider of veterinary medicines. One of the key aspects of its business model is the production of generics, offering cost-effective alternatives to branded products. This allows Aspen to establish a strong presence and achieve high market penetration in markets with limited investment requirements. The company has expanded its business in Europe and Asia, in addition to its strong presence in Africa. This geographical diversification allows Aspen to reach a broad customer base and minimize risks. Besides its products, Aspen also offers tailored services such as shipping, storage, and logistics management to ensure fast and efficient delivery to customers. The company has also expanded its presence in biopharmaceuticals through the acquisition of ThromboGenics in 2013, making it a leading provider of platelet activating factors. Aspen is committed to social responsibility and has initiated various initiatives to improve access to affordable medical products in Africa. Overall, Aspen Pharmacare Holdings Ltd's business model is based on its wide range of products and services, strategic focus on the African market, and effective implementation of its strategy, which has made it one of the largest and fastest-growing pharmaceutical companies in Africa.
'nin Aspen Pharmacare Holdings hasılatı 34,87 Md ZAR'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
'nin Aspen Pharmacare Holdings karı 2,65 Md ZAR'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Aspen Pharmacare Holdings'nin Fiyat/Kazanç (F/K) oranı şu anda 27,55'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Aspen Pharmacare Holdings hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Aspen Pharmacare Holdings'nin Fiyat/Satış (F/S) oranı şu anda 2,09'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Aspen Pharmacare Holdings hisse senedinin değerleme metriği olarak hizmet eder.
Aspen Pharmacare Holdings'nin Eulerpool Kalite Puanı 1/10'dur.
Aspen Pharmacare Holdings'nin ISIN'i ZAE000066692'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Aspen Pharmacare Holdings'nin WKN'i A0ET80'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Aspen Pharmacare Holdings'nin ticker'ı APN.JO'dir. Ticker sembolü, Aspen Pharmacare Holdings hisseleri borsada işlem görmek için kullanılır.
Aspen Pharmacare Holdings Hissesi
Aspen Pharmacare Holdings Emsaller Grubu
Aspen Pharmacare Holdings Ticker
Aspen Pharmacare Holdings FIGI
Aspen Pharmacare Holdings'nin tüm temel göstergeleri ve derinlemesine analizi
Aspen Pharmacare Holdings hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Aspen Pharmacare Holdings şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: